ARCHIVES

Senate Confirms FDA Commissioner Von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 44 | December 8, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

NCCS Networker Volume 4 Issue 1, Winter 1990

January 13, 1990

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013